MRI of stroke using hyperpolarized 129Xe

NMR in Biomedicine

Volumn 24, Issue 2, 2011, Pages 170-175

  Zhou, Xin ^a,b   Sun, Yanping ^b,c   Mazzanti, Mary ^b,c   Henninger, Nils ^c   Mansour, Joey ^b,c   Fisher, Marc ^c   Albert, Mitchell ^b,c  

^a Wuhan National Laboratory for Optoelectronics   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Hyperpolarized 129Xe; Infarct; Rat brain; Stroke MRI

Indexed keywords

BACKGROUND SIGNALS; BIOLOGICAL TISSUES; BLOOD FLOW; CEREBRAL BLOOD FLOW; CEREBRAL ISCHEMIA; CEREBRAL PERFUSION; COMPLEMENTARY TOOLS; CORE AREA; HYPERPOLARIZED; HYPERPOLARIZED XENON; HYPOPERFUSION; IN-VIVO; INFARCT; MIDDLE CEREBRAL ARTERY; NOVEL APPLICATIONS; OCCLUSION MODEL; PATHOPHYSIOLOGY; RAT BRAIN; STROKE MRI;

BLOOD; BLOOD VESSELS; HEMODYNAMICS;

MAGNETIC RESONANCE IMAGING;

PROTON; UNCLASSIFIED DRUG; XENON; XENON 129;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN PERFUSION; DIFFUSION WEIGHTED IMAGING; HISTOLOGY; HYPERPOLARIZATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; BRAIN; DIFFUSION; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; PROTONS; RATS; RATS, SPRAGUE-DAWLEY; STROKE; TIME FACTORS; XENON ISOTOPES;

RATTUS;

EID: 79951815813     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1568     Document Type: Article

References (43)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117(4): e25-146.
2. Fieschi C, Fisher M. Prevention of Ischemic Stroke, 1st edn. Informa Healthcare: London, 1999.
3. Mukherji SK, Chenevert TL, Castillo M. Diffusion-weighted magnetic resonance imaging. J. Neuroophthalmol. 2002; 22(2): 118-122.
4. Chien D, Kwong KK, Gress DR, Buonanno FS, Buxton RB, Rosen BR. MR diffusion imaging of cerebral infarction in humans. Am. J. Neuroradiol. 1992; 13(4): 1097-1102.
5. Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R. Measuring cerebral blood flow using magnetic resonance imaging techniques. J. Cereb. Blood Flow Metab. 1999; 19(7): 701-735.
6. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn. Reson. Med. 1996; 36(5): 726-736.
7. Fisher M. The Ischemic Penumbra: A New Opportunity for Neuroprotection. Cerebrovasc Dis. 2006; 21(Suppl. 2): 64-70.
8. Davis S, Fisher M, Warach S. Magnetic Resonance Imaging in Stroke, 1st edn. Cambridge University Press: Cambridge, 2003.
9. Back T, Hoehn-Berlage M, Kohno K, Hossmann KA. Diffusion nuclear magnetic resonance imaging in experimental stroke. Correlation with cerebral metabolites. Stroke 1994; 25(2): 494-500.
10. Busza AL, Allen KL, King MD, van BN, Williams SR, Gadian DG. Diffusion-weighted imaging studies of cerebral ischemia in gerbils. Potential relevance to energy failure. Stroke 1992; 23(11): 1602-1612.
11. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J. Cereb. Blood Flow Metab. 1996; 16(1): 53-59.
12. Sun PZ, Zhou J, Sun W, Huang J, van Zijl PC. Detection of the ischemic penumbra using pH-weighted MRI. J. Cereb. Blood Flow Metab. 2007; 27(6): 1129-1136.
13. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat. Med. 2003; 9(8): 1085-1090.
14. Wertman R, Altun E, Martin DR, Mitchell DG, Leyendecker JR, O'Malley RB, Parsons DJ, Fuller ER III, Semelka RC. Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology 2008; 248(3): 799-806.
15. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol. Dial. Transplant. 2006; 21(4): 1104-1108.
16. Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J. Am. Soc. Nephrol. 2006; 17(9): 2359-2362.
17. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am. J. Roentgenol. 2007; 188(2): 586-592.
18. 129Xe. Nature 1994; 370(6486): 199-201.
19. 129Xe dissolved in a lipid emulsion. C.R. Acad. Sci. III 2000; 323(6): 529-536.
20. Duhamel G, Choquet P, Grillon E, Leviel JL, Decorps M, Ziegler A, Constantinesco A. Global and regional cerebral blood flow measurements using NMR of injected hyperpolarized xenon-129. Acad. Radiol. 2002; 9 (Suppl 2): S498-S500.
21. Walker TG, Happer W. Spin-exchange optical pumping of noble-gas nuclei. Rev. Mod. Phys. 1997; 69: 629-642.
22. Zhou X, Luo J, Sun X, Zeng X, Ding S, Liu M, Zhan M. Enhancement of solid-state proton NMR via the spin-polarization-induced nuclear Overhauser effect with laser-polarized xenon. Phys. Rev. B 2004; 70: 052405-1-052405-4.
23. 2 line in flow system. Chin. Phys. Lett. 2004; 21: 1501-1503.
24. (129)Xe longitudinal relaxation time in the rat brain with noise considerations. NMR Biomed. 2008; 21(3): 217-225.
25. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20(1): 84-91.
26. Henninger N, Sicard KM, Schmidt KF, Bardutzky J, Fisher M. Comparison of ischemic lesion evolution in embolic versus mechanical middle cerebral artery occlusion in Sprague Dawley rats using diffusion and perfusion imaging. Stroke 2006; 37(5): 1283-1287.
27. Bouley J, Fisher M, Henninger N. Comparison between coated vs. uncoated suture middle cerebral artery occlusion in the rat as assessed by perfusion/diffusion weighted imaging. Neurosci. Lett. 2007; 412(3): 185-190.
28. 129Xe spectra from the heads of rats with and without ligation of the external carotid and pterygopalatine arteries. Magn. Reson. Med. 2005; 53(3): 528-534.
29. Wong EC, Cox RW, Song AW. Optimized isotropic diffusion weighting. Magn. Reson. Med. 1995; 34(2): 139-143.
30. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 1965; 42: 288-292.
31. Meng X, Fisher M, Shen Q, Sotak CH, Duong TQ. Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann. Neurol. 2004; 55(2): 207-212.
32. Bardutzky J, Shen Q, Henninger N, Bouley J, Duong TQ, Fisher M. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke 2005; 36(9): 2000-2005.
33. 129Xe NMR. Chem. Phys. Lett. 1998; 296: 391-396.
34. Kohno K, Hoehn-Berlage M, Mies G, Back T, Hossmann KA. Relationship between diffusion-weighted MR images, cerebral blood flow, and energy state in experimental brain infarction. Magn. Reson. Imaging 1995; 13(1): 73-80.
35. Kohno K, Back T, Hoehn-Berlage M, Hossmann KA. A modified rat model of middle cerebral artery thread occlusion under electrophysiological control for magnetic resonance investigations. Magn. Reson. Imaging 1995; 13(1): 65-71.
36. Bardutzky J, Shen Q, Henninger N, Schwab S, Duong TQ, Fisher M. Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging. Stroke 2007; 38(4): 1336-1344.
37. 129Xe. Phys. Rev. Lett. 2006; 96(5): 053002-1-053002-4.
38. Zhou X, Graziani D, Pines A. Hyperpolarized xenon NMR and MRI signal amplification by gas extraction. Proc. Natl. Acad. Sci. USA 2009; 106: 16903-16906.
39. 129Xe from blood into alveolar gas? Radiology 2009; 252(2): 319-321.
40. (129)Xe MRI: a viable functional lung imaging modality? Eur. J. Radiol. 2007; 64(3): 335-344.
41. 129Xe NMR as a probe for blood oxygenation. Magn. Reson. Med. 2000; 43(4): 491-496.
42. Schroder L, Lowery TJ, Hilty C, Wemmer DE, Pines A. Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor. Science 2006; 314(5798): 446-449.
43. Driehuys B. Chemistry. Toward molecular imaging with xenon MRI. Science 2006; 314(5798): 432-433.